Tag Archives: Depression

In Brief: Dr. Elizabeth Fitelson on Distinguishing Postpartum Depression from the Blues

In our clinic, we see many women with postpartum depression.  Some women know that something is wrong fairly soon after the depression sets in, and they seek help; however, far too many women present long after the onset of the depression, convinced that they are just suffering from the blues.  In this interview, Dr. Elizabeth… Read More »

Brexanolone (Zulresso) for Postpartum Depression Cleared by the DEA, Now Available

Brexanolone, to be marketed by Sage Therapeutics as Zulresso, was initially approved in March 2019, as a treatment for postpartum depression.  At that time, we were told that Zulresso would be available in June 2019. Here are a few updates. The Drug Enforcement Administration (DEA) has recommended that brexanolone be placed in schedule IV of… Read More »

Veterans Agency to Offer New Depression Drug, Despite Cost and Safety Concerns

Confronted by a rising rate of suicides in some groups of veterans., the Department of Veterans Affairs on Friday decided to approve the use of a new and costly depression drug, despite concerns among doctors and other experts about the drug’s effectiveness. The decision to endorse the drug — called Spravato, and manufactured by Janssen,… Read More »

Increased Identification of Women with Perinatal Depression, But Still Room for Improvement

Over the last decade, public awareness of the mental health challenges women face has grown tremendously, and we can say with certainty that we have succeeded in putting this important topic firmly on the medical map.  Still, the field of women’s mental health faces important challenges. How can we best serve women and the clinicians… Read More »